Oral suspension sulfonylurea safe, effective in children with neonatal diabetes

Children with neonatal diabetes switched from glibenclamide tablets to an oral suspension sulfonylurea therapy for 4 months experienced only mild adverse effects and no changes in HbA1c or incidence of hyperglycemia or hypoglycemia, according to findings from a phase 2 study published in Pediatric Diabetes.

Source: Oral suspension sulfonylurea safe, effective in children with neonatal diabetes

About the Author

cloudways

Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. The RDNutriScape Instagram

Tags:

Related Posts